CTRI/2020/09/027644
Completed
Phase 3
Comparison of acute antidepressant response of IV Ketamine versus oral Ketaminein treatment resistant depression
Dr P N Suresh Kumar0 sites61 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr P N Suresh Kumar
- Enrollment
- 61
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Failed 2 trial of different antidepressant class of adequate dose and duration.
- •2 Current depressive episode is of at least 4 weeks duration.
- •3 Not received ECT at least prior to enrollment.
Exclusion Criteria
- •1 Other psychiatric disorders.
- •2 Pregnancy and lactation.
- •3 Concurrent major life\-threatening illness like malignancy, cardiac failure, renal failure etc.
- •4 Alcohol and substance abuse and smokers.
- •5 Patients with electrocardiogram abnormality or abnormality on fundoscopy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Acute antidepressant effects and response predictors of wake therapyJPRN-jRCT1030220427Yoshiike Takuya60
Not yet recruiting
Phase 3
study on role of anti depression activity of ayurvedic medicinesCTRI/2022/08/044774Mahatma Gandhi Ayurveda College
Recruiting
Phase 2
Studying the antidepressant effects of intravenous ketamine in patients with major depressive disorderMajor Depressive DisorderMental Health - DepressionACTRN12615000566538ational University of Singapore30
Not yet recruiting
Not Applicable
Clinical evaluation of the antidepressant effect of the use of probiotics in bipolar disorderRBR-5dhhhddniversidade de São Paulo
Completed
Phase 2
Comparison of Venlafaxine and Sertraline Therapeutic Effects on Depression in Patients with EpilepsyIRCT20210608051515N2Tehran University of Medical Sciences30